Fact Sheet for Patients: Understanding Results from the CDC Novel Coronavirus 2012 Real-time RT-PCR Assay
May 30, 2013
If you have received this Fact Sheet, samples from your nose, throat, lungs, blood, or stool were taken to test if you may be infected with Middle East Respiratory Syndrome Coronavirus, also called “MERS-CoV” for short. Because there is a significant potential for a public health emergency involving MERS-CoV, federal authorities have specially authorized the use of the Centers for Disease Control and Prevention (CDC) Novel Coronavirus 2012 Real-time RT-PCR Assay (NCV-2012 rRT-PCR Assay) to test for the presence of MERS-CoV in clinical respiratory, blood, and stool samples.
This Fact Sheet contains information to help you understand the significant known and potential risks and benefits of the emergency use of the CDC NCV-2012 rRT-PCR Assay. If possible, you may want to discuss with your health care professional the benefits and risks described in this Fact Sheet.
What is Middle East Respiratory Syndrome Coronavirus Infection?
Middle East Respiratory Syndrome Coronavirus infection is a respiratory infection caused by a novel (new) coronavirus, called Middle East Respiratory Syndrome Coronavirus, or “MERS-CoV” for short. From April 2012 to May 2013, a total of 49 people from Saudi Arabia, Qatar, Jordan, the United Kingdom, the United Arab Emirates, France, and Tunisia were confirmed to have an infection caused by MERS-CoV. This virus can spread from person-to-person.
Most people diagnosed with MERS-CoV infection developed sudden severe respiratory illness with symptoms of fever, cough, and shortness of breath. A very few people confirmed to have MERS-CoV infection experienced mild respiratory illness.
MERS-CoV in humans could vary in severity from mild to severe. As of May 30, 2013, there are no reports of anyone in the United States getting infected and sick with MERS-CoV. However, public health officials have determined that MERS-CoV has a potential to spread to the United States and pose risks for the public health.
What is the CDC NCV-2012 rRT-PCR Assay?
The CDC NCV-2012 rRT-PCR Assay is a laboratory test designed to detect MERS-CoV. The Food and Drug Administration (FDA) has not cleared or approved this test. No FDA-cleared or FDA-approved tests exist that can identify MERS-CoV. However, based on data submitted to FDA by CDC, FDA has specially authorized the use of this test for this potential emergency.
Why is my sample being tested using the CDC NCV-2012 rRT-PCR Assay?
The sample collected from you will be tested using the CDC NCV-2012 rRT-PCR Assay to help determine whether you are infected with MERS-CoV. It may help your health care provider take better care of you. The test results could also help public health officials identify and limit the spread of this virus in your community.
What are the known risks and benefits of the CDC NCV-2012 rRT-PCR Assay?
Besides minimal potential discomfort during sample collection, a risk of incorrect test results exists. However, this risk is believed to be very small (see next paragraphs for more information). The benefit of having this test is that the results of this test, along with other information, can help your health care provider take better care of you. Also, knowing your test results would help you to take precautions to prevent the spread of the virus to your family or others.
If this test is positive, does it mean that I have MERS-CoV infection?
If you have a positive test, it is very likely that you have MERS-CoV infection. Although there is a very small chance that this test can give a positive result that is wrong (false positive), it is unlikely. If your result from this test is positive, your health care provider can determine how to care for you based on the test results, along with other factors.
If this test is negative, does it mean that I do not have MERS-CoV infection?
If you have a negative test, you probably do not have MERS-CoV infection and are most likely sick with something else. A very small chance exists that this test can give a negative result that is wrong (false negative), meaning you could possibly still have MERS-CoV infection even though the test is negative. A false negative result might cause any or all of the following: delayed treatment, potential lack of treatment, or stopping treatment too soon.
However, to avoid a false negative result affecting your care, your health care provider should not change your medical care solely based on a negative result. Instead, your health care provider should consider all other aspects of your illness along with your test result in deciding how to treat you.
How can I learn more?
Information about MERS-CoV and any significant new findings observed during the course of the emergency use of the CDC NCV-2012 rRT-PCR Assay will be made available at http://www.cdc.gov/coronavirus/ncv/index.html.
Please also contact your health care provider if you have any questions.